The authors analyzed the STS database for elective aortic root replacement (with several important exclusions) to derive risk factors for mortality and morbidity. A total of 8,807 patients met inclusion criteria.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic Valve
April 28, 2019
April 20, 2019
The American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), American Society of Echocardiography (ASE), Society for Cardiovascular Angiography and Interventions (SCAI), and Society of Thoracic Surgeons (STS) published a joint expert consensus and evidence-based recommendations for systems of care related to valvular he
April 18, 2019
Transcatheter aortic valve is usually implanted via transfemoral or transapical access. Reents and colleagues sought to compare the safety of these two access routes, using a retrospective analysis of their experience.
April 16, 2019
The authors present an aortic valve repair performed for a 34-year-old man with a history of tobacco use and hypertension.
April 13, 2019
The Stanford University cardiac surgery team expounds on current evidence for selection of prostheses in valve replacement. While more liberal usage of biologic prostheses in younger patients may be appropriate for the aortic valve, the support for this practice in the mitral position is not as strong.
April 11, 2019
The Heart Valve Society Annual Meeting 2019 streamed live from Sitges, Spain. Find the plenary sessions here.
April 10, 2019
Although both bicuspid aortic valve (BAV) and Marfan syndrome have been associated with aortic dissection risk, it is unknown if the presence of BAV is associated with an increased aortic risk in patients with an FBN1 gene mutation.
April 9, 2019
This video demonstrates the technique of the "Commando procedure" to treat invasive double valve endocarditis that involves the aortomitral fibrous body.
April 8, 2019
This review provides a comprehensive overview of the available data on antithrombotic therapy after transcatheter aortic valve replacement.
March 25, 2019
Andreas and colleagues report their experience of aortic valve replacement with rapid-deployment surgical aortic valves prostheses in 500 patients over seven years. The authors found a 0.8% 30-day mortality, and the valves showed excellent hemodynamic performance, durability, and safety with a median follow-up time of 12 months.